Abstract
A lamb model of pulmonary hypertension, developed by inserting an aortopulmonary vascular graft (shunt), displays vascular remodeling and increased pulmonary blood flow characteristic of children with congenital heart disease. The purpose of this study was to determine whether expression of fibroblast growth factor-2 (FGF-2), a smooth muscle cell mitogen, is altered in shunt lambs. FGF-2 mRNA and protein levels were increased in lung tissue extracts from shunt lambs at 4 wk of age relative to age-matched controls (p < 0.05). FGF-2 protein levels were also increased in the pulmonary arteries and serum of shunt lambs (p < 0.05). Pulmonary arterial smooth muscle cells (PASMC) and endothelial cells (PAEC) were isolated from 4 wk-old lambs and subjected to cyclic stretch and laminar shear stress to mimic increased pulmonary blood flow. Stretch and shear increased FGF-2 promoter activity, and intracellular and extracellular FGF-2 protein levels in both cell types (p < 0.05). Exogenous FGF-2 stimulated PASMC proliferation at levels detected in the extracellular medium of sheared cells (p < 0.05). Elevated FGF-2 signaling by PASMC and PAEC exposed to increased pulmonary blood flow may play a role in the pulmonary vascular remodeling associated with the shunt model of pulmonary hypertension secondary to congenital heart disease.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- CHD:
-
congenital heart disease
- EC:
-
endothelial cells
- ET-1:
-
endothelin-1
- ETA:
-
endothelin A receptor
- FGF-2:
-
fibroblast growth factor-2
- PAEC:
-
pulmonary arterial endothelial cells
- PASMC:
-
pulmonary arterial smooth muscle cells
- SMC:
-
smooth muscle cells
References
Hoffman JI, Rudolph AM, Heymann MA 1981 Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64: 873–877
Nagumo K, Yamaki S, Takahashi T 2000 Extremely thickened media of small pulmonary arteries in fatal pulmonary hypertension with congenital heart disease—a morphometric and clinicopathological study. Jpn Circ J 64: 909–914
Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG, Trusler GA, Rowe RD, Olley PM, Cutz E 1986 Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 55: 632–653
Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, Fineman JR 1995 In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606–613
Black SM, Fineman JR, Steinhorn RH, Bristow J, Soifer SJ 1998 Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 275: H1643–H1651
Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR 2000 Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97–106
Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM 1978 Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58: 1107–1122
Mata-Greenwood E, Meyrick B, Steinhorn RH, Fineman JR, Black SM 2003 Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 285: L209–L221
Mata-Greenwood E, Meyrick B, Soifer SJ, Fineman JR, Black SM 2003 Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 285: L222–L231
Casscells W, Lappi DA, Olwin BB, Wai C, Siegman M, Speir EH, Sasse J, Baird A 1992 Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci U S A 89: 7159–7163
Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA 1991 Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68: 106–113
Hanna AK, Fox JC, Neschis DG, Safford SD, Swain JL, Golden MA 1997 Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury. J Vasc Surg 25: 320–325
Arcot SS, Fagerland JA, Lipke DW, Gillespie MN, Olson JW 1995 Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats. Growth Factors 12: 121–130
Benisty JI, McLaughlin VV, Landzberg MJ, Rich JD, Newburger JW, Rich S, Folkman J 2004 Elevated fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest 126: 1255–1261
Wang DM, Tarbell JM 1995 Modeling interstitial flow in an artery wall allows estimation of wall shear stress on smooth muscle cells. J Biomech Eng 117: 358–363
Quinn TP, Schlueter M, Soifer SJ, Gutierrez JA 2002 Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 282: L897–L903
Rhoads DN, Eskin SG, McIntire LV 2000 Fluid flow releases fibroblast growth factor-2 from human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 416–421
Gloe T, Sohn H, Meininger G, Pohl U 2002 Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3. J Biol Chem 277: 23453–23458
Black SM, Johengen MJ, Ma ZD, Bristow J, Soifer SJ 1997 Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs. J Clin Invest 100: 1448–1458
McMullan DM, Bekker JM, Johengen MJ, Hendricks-Munoz K, Gerrets R, Black SM, Fineman JR 2001 Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am J Physiol Heart Circ Physiol 280: H777–H785
Wedgwood S, Dettman RW, Black SM 2001 ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281: L1058–L1067
Wedgwood S, Mitchell CJ, Fineman JR, Black SM 2003 Developmental differences in the shear stress-induced expression of endothelial NO synthase: changing role of AP-1. Am J Physiol Lung Cell Mol Physiol 284: L650–L662
Dewey CF Jr, Bussolari SR, Gimbrone MA, Davies PF 1981 The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 103: 177–185
Dobrin PB 1978 Mechanical properties of arteries. Physiol Rev 58: 397–460
Malek AM, Gibbons GH, Dzau VJ, Izumo S 1993 Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest 92: 2013–2021
Passerini AG, Milsted A, Rittgers SE 2003 Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J Vasc Surg 37: 182–190
Tulis DA, Prewitt RL 1998 Medial and endothelial platelet-derived growth factor A chain expression is regulated by in vivo exposure to elevated flow. J Vasc Res 35: 413–420
Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr Gimbrone MA Jr 1993 Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A 90: 4591–4595
Sumpio BE, Du W, Galagher G, Wang X, Khachigian LM, Collins T, Gimbrone MA Jr, Resnick N 1998 Regulation of PDGF-B in endothelial cells exposed to cyclic strain. Arterioscler Thromb Vasc Biol 18: 349–355
Mata-Greenwood E, Grobe A, Kumar S, Noskina Y, Black SM 2005 Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-beta1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am J Physiol Lung Cell Mol Physiol 289: L288–L298
Song RH, Kocharyan HK, Fortunato JE, Glagov S, Bassiouny HS 2000 Increased flow and shear stress enhance in vivo transforming growth factor-beta1 after experimental arterial injury. Arterioscler Thromb Vasc Biol 20: 923–930
Brogi E, Wu T, Namiki A, Isner JM 1994 Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649–652
Stachowiak MK, Fang X, Myers JM, Dunham SM, Berezney R, Maher PA, Stachowiak EK 2003 Integrative nuclear FGFR1 signaling (INFS) as a part of a universal “feed-forward-and-gate” signaling module that controls cell growth and differentiation. J Cell Biochem 90: 662–691
Bassus S, Herkert O, Kronemann N, Gorlach A, Bremerich D, Kirchmaier CM, Busse R, Schini-Kerth VB 2001 Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species. Arterioscler Thromb Vasc Biol 21: 1550–1555
Li P, Oparil S, Sun JZ, Thompson JA, Chen YF 2003 Fibroblast growth factor mediates hypoxia-induced endothelin—a receptor expression in lung artery smooth muscle cells. J Appl Physiol 95: 643–651
Powers MR, Planck SR, Berger J, Wall MA, Rosenbaum JT 1994 Increased expression of basic fibroblast growth factor in hyperoxic-injured mouse lung. J Cell Biochem 56: 536–543
Jankov RP, Kantores C, Belcastro R, Yi S, Ridsdale RA, Post M, Tanswell AK 2005 A model for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 288: L1162–L1170
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported, in part, by grant 0330292N from the American Heart Association National Office (SW) and grants HL60190 (SMB), HL67841 (SMB), HL072123 (SMB), HL070061 (SMB), and HL61284 (JRF) from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Wedgwood, S., Devol, J., Grobe, A. et al. Fibroblast Growth Factor-2 Expression Is Altered in Lambs With Increased Pulmonary Blood Flow and Pulmonary Hypertension. Pediatr Res 61, 32–36 (2007). https://doi.org/10.1203/01.pdr.0000250013.77008.28
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000250013.77008.28
This article is cited by
-
Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
Clinical and Experimental Nephrology (2017)
-
Mechanisms of disease: pulmonary arterial hypertension
Nature Reviews Cardiology (2011)
-
Targeting non-malignant disorders with tyrosine kinase inhibitors
Nature Reviews Drug Discovery (2010)
-
Cardiac microvascular endothelial cells express and release nerve growth factor but not fibroblast growth factor-2
In Vitro Cellular & Developmental Biology - Animal (2010)
